Medicine
Soltamox 20 mg/10 mL oral liquid
Soltamox 20 mg/10 mL oral liquid is a prescription medicine containing Tamoxifen for oral use, marketed by Mayne Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
DO NOT freeze or refrigerate. Store at room temperatures 20° to 25°C (68° -…
Key facts
- Active ingredient (INN)
- Tamoxifen
- Brand
- Soltamox
- Strength
- 20 mg/10 mL
- Dosage form
- Oral liquid
- Route
- Oral
- Packs
- 1 container
- Marketing authorisation holder
- Mayne Pharma
- Manufacturer
- Mayne Pharma
- Origin register
- US FDA, United States
- Storage
- DO NOT freeze or refrigerate. Store at room temperatures 20° to 25°C (68° - 77°F), excursions permitted between 15° to 30°C (59° - 86°F). Store in original packaging in order to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BA01 Tamoxifen
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 June 2021
- Identifiers
- RxCUI 389230, 644304DailyMed set ID 1e6ff055-590c-41e6-9530-1fdf04cdbd02NDC 51862-682Application NDA021807
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 container in 1 carton / 150 mL in 1 container | 51862-682-00 | Mayne Pharma | 6 December 2021 |
| 1 container in 1 carton / 150 mL in 1 container | 51862-682-01 | Mayne Pharma | 18 June 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1977 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tamoxifen
Clinical summary
Tamoxifen is an estrogen agonist/antagonist indicated for treatment of adult patients with estrogen receptor-positive metastatic breast cancer, among other approved uses. It is available as tablets and oral liquid. MedsAcross supplies Tamoxifen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TamoxifenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SOLTAMOX prescribing information (Mayne Pharma) · U.S. National Library of Medicine, DailyMed
Need Soltamox 20 mg/10 mL oral liquid for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.